Trials / Completed
CompletedNCT05769855
A Study of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Group, Active and Placebo Controlled Study to Evaluate the Efficacy and Safety of Local Administration of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 294 (actual)
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the efficacy, and safety of HR18034 for postoperative analgesia in subjects undergoing hemorrhoidectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HR18034 | HR18034 380mg |
| DRUG | ropivacaine HCl | ropivacaine HCl 75mg. |
| DRUG | Sodium Chloride Physiological Solution | Sodium Chloride Physiological Solution 20ml |
Timeline
- Start date
- 2023-03-21
- Primary completion
- 2023-10-30
- Completion
- 2023-10-30
- First posted
- 2023-03-15
- Last updated
- 2024-03-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05769855. Inclusion in this directory is not an endorsement.